文献速递脑血管病神经重症与神经感染

PPARγ激动剂通过静息态星形胶质细胞加速急性脑出血MRI信号消退

PPARγ Agonists Accelerate MRI Signal Resolution Mediated by Resting-State Astroglia in Acute Intracerebral Hemorrhage.
PubMed 文献 · Stroke · 2025-07-16

本研究在大鼠胶原酶诱导的脑出血模型中,用钙通道阻滞剂pyr3抑制星形胶质细胞活性,或联合PPARγ激动剂(罗格列酮、吡格列酮)干预,通过T2加权MRI观察血肿演变。结果显示pyr3延迟血肿信号转变,联合罗格列酮可逆转延迟并稍减小血肿体积,联合吡格列酮改善运动行为和步态并降低脑含水量;培养星形胶质细胞中联合处理增加HCP-1表达和血红素摄取。结论为联合pyr3与PPARγ激动剂可加速静息态星形胶质细胞早期吸收血红素铁,改善后期功能并减轻水肿。

要点

  • pyr3抑制星形胶质细胞活性可延迟脑出血后血肿T2信号转变。
  • 罗格列酮联合pyr3可逆转信号延迟并稍减小血肿体积。
  • 吡格列酮联合pyr3改善运动行为、步态并降低脑含水量。

核心结论

  • 联合pyr3与PPARγ激动剂加速静息态星形胶质细胞早期吸收血红素铁,改善后期功能并减轻水肿。

研究设计与样本

  • 大鼠纹状体内注射细菌胶原酶诱导脑出血,随机分为6组:溶媒、pyr3、罗格列酮、吡格列酮、pyr3+罗格列酮、pyr3+吡格列酮。
  • 药物在脑出血诱导后10分钟经对侧脑室注射给药,用T2加权MRI观察前21小时血肿演变。
  • 采用运动行为测试和弥散加权成像评估较长期功能结局和水肿,并用星形胶质细胞系体外实验评估血红素摄取。

主要发现

  • pyr3处理组在T2加权图像上出现血肿信号转变延迟,见于不同脑出血模型(ANOVA;P<0.001)。
  • 加用罗格列酮可挽救延迟的信号转变(ANOVA;P<0.01),并稍减小血肿体积(ANOVA;P<0.001)。
  • pyr3+吡格列酮组较溶媒组改善运动行为(ANOVA;P<0.001)、步态(ANOVA;P<0.001)并降低脑含水量(ANOVA;P<0.01)。
  • 培养星形胶质细胞中联合处理组在数小时内增加HCP-1表达和血红素摄取(P<0.001)。

关键数值与推荐

  • pyr3延迟血肿信号转变的组间差异:ANOVA P<0.001。
  • 罗格列酮挽救信号延迟:ANOVA P<0.01;血肿体积减小:ANOVA P<0.001。
  • pyr3+吡格列酮改善运动行为与步态:ANOVA P<0.001;降低脑含水量:ANOVA P<0.01。
  • 体外联合处理增加HCP-1表达和血红素摄取:P<0.001。

临床怎么用

  • 提示调控星形胶质细胞活性联合PPARγ激动剂可能促进脑出血后血肿清除并改善功能结局。
  • 罗格列酮与吡格列酮在联合pyr3时表现出不同的影像与功能获益,需进一步区分适用场景。

局限性

  • 证据来自大鼠胶原酶诱导脑出血模型及星形胶质细胞系体外实验,尚未在人体验证。
  • 药物经脑室注射给药,与临床全身给药途径不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the aftermath of intracerebral hemorrhage (ICH), the clearance of harmful substances from the hematoma helps to mitigate brain edema and reduce the risk of subsequent neurological damage. This study aimed to investigate the mechanism underlying early hematoma processing following ICH and to explore the potential of modulating this process via astrocyte regulation. METHODS: ICH was induced by intrastriatal injection of bacterial collagenase. A calcium channel blocker, pyr3 (ethyl 1-[4-(2,3,3-trichloroprop-2-enoylamino)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate), was used to suppress astrocyte activity, or combined with PPARγ (peroxisome proliferator-activated receptor gamma) agonists (rosiglitazone and pioglitazone) as the intervention approach. The rats were randomly assigned to the following groups: ICH with vehicle treatment, ICH with pyr3 treatment, ICH with rosiglitazone treatment, ICH with pioglitazone treatment, ICH with pyr3 and rosiglitazone treatment, and ICH with pyr3 and pioglitazone treatment. Drugs were administered via the intraventricular route into the contralateral ventricle 10 minutes after ICH induction. The evolution of hematoma within the first 21 hours was meticulously examined using T2-weighted magnetic resonance imaging. Motor behavioral testing and diffusion-weighted imaging were used to assess longer-lasting functional outcomes and edema. To assess astrocyte-specific responses, an astrocyte cell line was incubated with hemin followed by different drug treatments. An intracellular hemin assay was used to quantify the hemin uptake capacity of astrocytes. RESULTS: Delayed signaling transitions of the hematoma were observed in the ICH with pyr3 treatment group in T2-weighted images, manifesting in different ICH models (ANOVA; P<0.001). The additional treatment of rosiglitazone rescued the delayed signaling transition (ANOVA; P<0.01) with a slight reduction in hematoma volume (ANOVA; P<0.001). ICH with pyr3 and pioglitazone treatment group exhibited improved motor behavior (ANOVA; P<0.001), gait (ANOVA; P<0.001), and reduced brain water content (ANOVA; P<0.01) than ICH with the vehicle treatment group. In cultured astrocytes, the combined treatment group showed increased HCP-1 (heme carrier protein-1) expression and hemin uptake within a few hours (P<0.001). CONCLUSIONS: Combined treatment with the calcium channel blocker, pyr3, and the PPARγ agonist accelerated the early absorption of heme iron by resting-state astrocytes, leading to improved functional performance and reduced edema in later stages.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chiu YP, Ji HR, Yang YC, et al. PPARγ Agonists Accelerate MRI Signal Resolution Mediated by Resting-State Astroglia in Acute Intracerebral Hemorrhage. Stroke. 2025. PMID: 40665921. doi:10.1161/STROKEAHA.124.048584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。